| CAT # | Product Name | Description |
| CPD100391 | SHP394 | |
| CPD100390 | SHP389 (free base) | |
| CPD3242 | RMC-4550 | RMC-4550 is a potent and selective SHP2 inhibitor. RMC-4550 identified as a high quality tool compound to study the role of SHP2 in tumor biology, both in vitro and in vivo in rodents. SHP2 is a convergent signalling node and inhibition of SHP2 is effective in targeting both upstream (RTK-driven) and downstream (RAS-GTP dependent) mutations in the RAS-MAPK pathway |